Clinical Trial Update: tACS Modulates Speech and Cognitive Impairments in People With PD by Targeting the Medial Frontal Cortex [NA]

View source ↗

Summary

This clinical trial update reports that transcranial alternating current stimulation targeting the medial frontal cortex was studied for speech and cognitive im…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Snippet

Sponsor: Ke Dong, MD | Conditions: Parkinson Disease | NA | Status: COMPLETED